Clear Cell SarcomaSymptoms, Doctors, Treatments, Advances & More
Clear Cell Sarcoma Overview
Learn About Clear Cell Sarcoma
Heber Valley Specialty Clinic - Urology
Richard Vanlangendonck, MD is a urologist at Intermountain Health’s Heber Valley Specialty Clinic in Hever City, Utah, and Jerry & Kathleen Grundhofer Clinic – Urology in Park City, Utah. He supports patients in Park City, Snyderville, Kamas, Francis, Woodland, Heber City, and surrounding communities, treating prostate cancer, kidney cancer, adrenal cancer, bladder cancer, and more. His clinical interests focus on robotic surgery for the treatment of prostate and kidney cancer. He is passionate about this technology's advanced capabilities, allowing for precise and minimally invasive procedures that significantly benefit his patients. Dr. Vanlangendonck is deeply committed to providing his patients with the highest standard of care. Guided by his philosophy of being the best doctor and person he can be, he treats each individual with compassion and respect. Committed to excellence, the Louisiana native continually strives to perfect his craft. He takes great pride in delivering outstanding patient care and ensuring that each patient is satisfied.Potential patients should know that Dr. Vanlangendonck excels in his field and is passionate about his expertise. He brings this expertise to his practice every day, providing his patients with the highest level of care and support throughout their wellness journey.Conditions Treated: Prostate CancerKidney CancerAdrenal CancerBladder CancerKidney and Ureteral StonesBenign Prostatic Hyperplasia Elevated PSAVoiding Dysfunction Erectile DysfunctionProcedures Performed: Robotic Urologic Surgery for Urologic Cancers Robotic Urologic Surgery for Urinary Obstruction Ureteroscopy Transurethral Surgery for Bening and Malignant DiseaseCystoscopyTransrectal and Transperineal Ultrasound with Prostate BiopsyVasectomy. Dr. Vanlangendonck is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Reconstructive Urology Surgery, and Nephrectomy. Dr. Vanlangendonck is board certified in American Board Of Urology. Dr. Vanlangendonck is currently accepting new patients.
Advocate Infusion Center
Jerry Liu is a Hematologist and an Oncologist practicing medicine in Crystal Lake, Illinois. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Anemia, and Bone Marrow Aspiration. Dr. Liu is board certified in American Board Of Internal Medicine, Hematology.
Advocate Lutheran General Cancer Institute
Timothy Lestingi is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Lestingi is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Ureteroscopy, and Gastrostomy. Dr. Lestingi is board certified in American Board Of Internal Medicine, Medical Oncology.
Summary: 3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells genetically engineered to express B7-H3-CARs for patients ≤ 21 years old, with relapsed/refractory B7-H3+ solid tumors. This study will evaluate the safety and maximum tolerated dose of B7-H3-CAR T cells.The purpose of this study is to find the ...
Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small percentage of these tumors are familial. Researchers want to study these changes in biological samples from people with rare tumors in order to learn more about how these tumors develop. The information obtained from this study may lead to improved screen...


